menu
    • menu
    [{"orgOrder":0,"company":"Inner Mongolia Yili Industrial Group Co., Ltd","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Protein","year":"2012","type":"Inapplicable","leadProduct":"Lactoferrin","moa":"Tryptase alpha\/beta-1 (Tryptase)","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Inner Mongolia Yili Industrial Group Co., Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Inner Mongolia Yili Industrial Group Co., Ltd \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Inner Mongolia Yili Industrial Group Co., Ltd \/ Undisclosed"},{"orgOrder":0,"company":"Beingmate Baby & Child Food Co Ltd .","sponsor":"Sir Run Run Shaw Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"CHINA","productType":"Protein","year":"2017","type":"Inapplicable","leadProduct":"Lactoferrin","moa":"Tryptase alpha\/beta-1 (Tryptase)","graph1":"Hematology","graph2":"Undisclosed","graph3":"Beingmate Baby & Child Food Co Ltd .","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beingmate Baby & Child Food Co Ltd . \/ Sir Run Run Shaw Hospital","highestDevelopmentStatusID":"1","companyTruncated":"Beingmate Baby & Child Food Co Ltd . \/ Sir Run Run Shaw Hospital"},{"orgOrder":0,"company":"Xigo Health LLC","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Protein","year":"2010","type":"Inapplicable","leadProduct":"Lactoferrin","moa":"Tryptase alpha\/beta-1 (Tryptase)","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Xigo Health LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Xigo Health LLC \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Xigo Health LLC \/ Undisclosed"},{"orgOrder":0,"company":"Ventria Bioscience","sponsor":"National Institute on Aging","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"U.S.A","productType":"Protein","year":"2011","type":"Inapplicable","leadProduct":"Lactoferrin","moa":"Tryptase alpha\/beta-1 (Tryptase)","graph1":"Gastroenterology","graph2":"Phase III","graph3":"Ventria Bioscience","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ventria Bioscience \/ National Institute on Aging","highestDevelopmentStatusID":"10","companyTruncated":"Ventria Bioscience \/ National Institute on Aging"},{"orgOrder":0,"company":"Utah State University","sponsor":"Glanbia Nutritionals","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Protein","year":"2024","type":"Inapplicable","leadProduct":"Lactoferrin","moa":"Tryptase alpha\/beta-1 (Tryptase)","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Utah State University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Utah State University \/ Glanbia Nutritionals","highestDevelopmentStatusID":"1","companyTruncated":"Utah State University \/ Glanbia Nutritionals"},{"orgOrder":0,"company":"Egymedicalpedia","sponsor":"Al-Azhar University","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Protein","year":"2024","type":"Inapplicable","leadProduct":"Lactoferrin","moa":"Tryptase alpha\/beta-1 (Tryptase)","graph1":"Hematology","graph2":"Undisclosed","graph3":"Egymedicalpedia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Egymedicalpedia \/ Al-Azhar University","highestDevelopmentStatusID":"1","companyTruncated":"Egymedicalpedia \/ Al-Azhar University"},{"orgOrder":0,"company":"Helaina Inc.","sponsor":"Biofortis M\u00e9rieux Nutriscience","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Protein","year":"2025","type":"Inapplicable","leadProduct":"Lactoferrin","moa":"Tryptase alpha\/beta-1 (Tryptase)","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Helaina Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Helaina Inc. \/ Biofortis M\u00e9rieux Nutriscience","highestDevelopmentStatusID":"1","companyTruncated":"Helaina Inc. \/ Biofortis M\u00e9rieux Nutriscience"}]

    Find Clinical Drug Pipeline Developments & Deals for Lactoferrin

    Menu

    Lactoferrin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Helaina Inc.

                            Country arrow
                            CPhI India
                            Not Confirmed

                            Helaina Inc.

                            Country arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Biofortis Mérieux Nutriscience

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability

                            Details : Lactoferrin is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            June 25, 2025

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Biofortis Mérieux Nutriscience

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Egymedicalpedia

                            Country arrow
                            CPhI India
                            Not Confirmed

                            Egymedicalpedia

                            Country arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Hematology

                            Study Phase : Undisclosed

                            Sponsor : Al-Azhar University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Lactoferrin Alone ,Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency Anemia

                            Details : Lactoferrin is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Anemia, Iron-Deficiency.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            September 19, 2024

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Hematology

                            Highest Development Status : Undisclosed

                            Sponsor : Al-Azhar University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Utah State University

                            Country arrow
                            CPhI India
                            Not Confirmed

                            Utah State University

                            Country arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Glanbia Nutritionals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Lactoferrin-enriched Whey on Iron Status in Females

                            Details : Lactoferrin is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            January 31, 2024

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Glanbia Nutritionals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Beingmate Baby & Child Food Co Ltd .

                            Country arrow
                            CPhI India
                            Not Confirmed

                            Beingmate Baby & Child Food Co Ltd .

                            Country arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Hematology

                            Study Phase : Undisclosed

                            Sponsor : Sir Run Run Shaw Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Lactoferrin Supplementation and Iron Metabolism in Healthy Pregnant Women

                            Details : Lactoferrin is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Anemia, Iron-Deficiency.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            April 21, 2017

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Hematology

                            Highest Development Status : Undisclosed

                            Sponsor : Sir Run Run Shaw Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Inner Mongolia Yili Industrial Group Co., Ltd

                            Country arrow
                            CPhI India
                            Not Confirmed

                            Inner Mongolia Yili Industrial Group Co., Ltd

                            Country arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization

                            Details : Lactoferrin is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Influenza, Human.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            September 03, 2012

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Ventria Bioscience

                            Country arrow
                            CPhI India
                            Not Confirmed

                            Ventria Bioscience

                            Country arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Gastroenterology

                            Study Phase : Phase III

                            Sponsor : National Institute on Aging

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adul...

                            Details : Lactoferrin is a Protein drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Diarrhea.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            June 27, 2011

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Phase III

                            Sponsor : National Institute on Aging

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Xigo Health LLC

                            Country arrow
                            CPhI India
                            Not Confirmed

                            Xigo Health LLC

                            Country arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety and Efficacy Study of Oral XIGO Tablets to Treat The Common Cold

                            Details : Lactoferrin is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Common Cold.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            March 24, 2010

                            Lead Product(s) : Lactoferrin

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth